Akademik Veri Yönetim Sistemi
16th International Congress of Update in Cardiology and Cardiovascular Surgery, Antalya, Türkiye, 30 Ekim - 01 Kasım 2020, ss.643-644, (Özet Bildiri)
PROTECTIVE EFFECTS OF METFORMIN ON THE PROCESS OF ATHEROSCLEROSIS WITH AGING IN THE RAT HEART
Ozgur Baris1, Gokhan Duruksu2, Gulcin Gacar2, Ipek Komsuoglu Celikyurt3, Yusufhan Yazir2, Tijen Utkan3
1University of Health Sciences Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey
2Center for Stem Cell and Gene Therapies Research and Practice, Kocaeli University, School of Medicine, Kocaeli, Turkey
3Kocaeli University, School of Medicine, Kocaeli, Turkey
*Corresponding Author (drozgurbaris@gmail.com)
PROTECTIVE EFFECTS OF METFORMIN ON THE PROCESS OF ATHEROSCLEROSIS WITH AGING IN THE RAT HEART
OBJECTIVE
For cardiovascular protection, many pharmacological agents provide clues as to where the protective effects about insulin resistance and metabolic syndrome associated with atherosclerosis remain the focus of interest. Although developed as an
antidiabetic drug, Metformin is still up to date with effective research showing its positive contribution to many anti-inflammatory processes.
With this laborious study on the elderly rat heart, we hope that the protective effect of metformin in the process of atherosclerosis will make an effective contribution to larger-scale studies, particularly vascular pathologies.
METHODS
Wistar-Albino male rats were separated into four groups: young mice(< 12months-old),young mice&metformin, old mice (24months- old),old mice& metformin. Metformin was supplemented into drinking water at concentration of 100mg/kg for 8 weeks. The apical half of left ventricle was excised. The effects on cardiac tissue cells in aging rat was evaluated by expression analysis of
proliferation(Ki67), oxidative stress(Superoxide Dismutase 1, SOD1) and inflammation (Transforming growth factor beta(TGF-β), Tumor necrosis factor - α (TNF-α), Interleukin-1β (IL-1β), Inducible nitric oxide synthase(i-NOS) markers. The expression of pericyte
marker, PDGFR-β (Platelet derived growth factor receptor- β), was also estimated in tissue.
RESULTS
When compared to young tissue, expression of TGF-β, TNF-α and IL-1β were increased in tissue of aged tissue at rate of 1.89,
1.27 and 1.09-fold, respectively. Oral consumption of metformin by aged rat attenuated the expression of these inflammatory markers to levels of 1.41 (p=0.044), 1.03 (p>0.05) and 0.97-fold (p>0.05), respectively.
The SOD1 expression was increased in metformin groups. In young tissue, SOD1 expression was improved 1,89-fold (p=0.021) after metformin. Anti-oxidative capacity was slightly decreased in aged tissue (0.84-fold) when compared to young’s. SOD1- expression in old mice treated with metformin was improved to 2.67-fold (p=0.015). Cell proliferation in aged group with metformin was substantially improved (3.26-fold, p=0.007) compared to young animals. The i-NOS expression was also decreased after metformin treatment in aged animals, while no effect could be observed in young animals in both treated and non-treated groups. PDGFR-β expression level in young tissue was decreased slightly to 0.89-fold, while PDGFR-β expression was increased in aged
tissue from 1.54-fold (p=0.056) to 1.78-fold (p=0.043).
CONCLUSIONS
Metformin supports pericytes and enhanced regeneration capacity, which deteriorated with aging. Metformin treatment strengthened antioxidant capacity and attenuated inflammation indicators in the aged group. Metformin may have a preventive effect
on the process of atherosclerosis.